starting dose semaglutide ᐅ What to expect on • HealthExpress® Semaglutide Starting Dose & Personalized

Semaglutide is currently being investigated in two large phase III clinical trial programs for treating obesity: the STEP program, which aims to obtain regulatory approval for semaglutide as an anti-obesity drug and is evaluating cardiovascular outcomes in 17,500 patients

For these reasons, it can be a viable option for individuals looking to lose weight

The efficacy of semaglutide in weight management has been demonstrated in numerous clinical trials, where participants receiving the medication showed greater weight loss compared to those on a placebo

Wegovy is FDA-approved to support long-term weight management when used with healthy eating and physical activity

Understanding proper GLP-1 injection technique and the best injection sites for GLP-1 ensures consistent results regardless of where you are in the world